Howard Fischer
Mr. Fischer has extensive experience on both the sell-side and buy-side of the securities and advisory businesses. Howard serves as one of our lead healthcare investment bankers. He has held senior investment banking positions at UBS Global Investment Banking, Prudential Securities, and Furman Selz. Mr. Fischer was an analyst and portfolio manager at Silverback Asset Management, a $1.5 billion fund, as well as at SCO Financial Group, a fund that took controlling positions in distressed publicly-traded companies. For many years Mr. Fischer specialized in healthcare, but also has extensive experience in an array of industries including consumer/retail, media/entertainment, financial services, energy, and special situations. He has considerable experience in public and private capital raising, mergers and acquisitions, restructurings, and related transactions. Mr. Fischer has served as an independent advisor to some of the largest private equity groups, hedge funds, and venture capital firms in the country and has served as an expert witness for clients in major valuation, securities, and investment banking-related cases.. Mr. Fischer received an MBA from the Booth School of Business at the University of Chicago and a BS from the Wharton School of the University of Pennsylvania. He is a CPA.
Dana Levy-Germain
Ms. Levy-Germain has over two decades of professional fundraising experience. Since 1998, she has marketed private equity and venture capital funds targeting international and domestic institutional investors. She has raised initial venture capital for entrepreneurs seeking institutional capital and has brought institutional investors into later round capital raises for growing companies. Prior to 1998, Ms. Levy-Germain was the Vice President of the International Fund for Renewable Energy and Efficiency in Washington DC. She has also held international marketing and business development positions with the Pacific Asia Travel Association in Singapore and Shiseido in Tokyo. Ms. Levy-Germain holds a MBA from ASU’s Thunderbird School of Global Management, as well as a BA and MS from the University of Cincinnati.
Eric Singer
Mr. Singer’s focus is raising capital for small companies. Most recently, Mr. Singer raised $56 million in three rounds for NeoTX, an Israeli biopharmaceutical company that develops anti-cancer immunotherapies. Mr. Singer wrote Trade the Congressional Effect: How to Profit from the Congressional Effect, a Wiley-published book about the impact of the US Congress on the stock market. He has also written articles for Investor’s Business Daily and Forbes. During the 1990s, Mr. Singer was head of Corporate Finance at Gerard Klauer Mattison & Co., Inc., a research-oriented brokerage firm. In the 1980s, he launched a corporate finance new products group at Smith Barney and headed a similar group at PaineWebber. He graduated Phi Beta Kappa from SUNY at Stony Brook and earned a JD from Cornell Law School, where he was a member of the Cornell Law Review.